Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2023-10-27 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding the top ten shareholders and top ten unrestricted shareholders' shareholding status prior to a share repurchase plan. It references a board meeting approving a share repurchase plan and provides detailed shareholding tables. The document is short (1489 characters) and focuses on shareholder holdings related to a share repurchase, not on financial results or management changes. It is not a full financial report, earnings release, or management report. It is also not a voting result or AGM material. The content fits best with a Transaction in Own Shares (POS) filing, which covers announcements about share buybacks or repurchases. Confidence is high given the clear focus on share repurchase and shareholder holdings.
2023-10-27 Chinese
股份回购报告书
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding a share repurchase plan. It includes specifics about the purpose, amount, price limits, implementation period, funding source, and expected impact on the company's capital structure. It also discusses regulatory compliance, board approval, risk factors, and disclosure obligations related to the share buyback. The document is not a financial report, earnings release, or management discussion but a formal report on the company's share repurchase activity. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back its own shares. The document length (7835 characters) and content confirm it is the actual report, not just an announcement of a report publication or a brief notice. Therefore, the correct classification is POS with high confidence.
2023-10-27 Chinese
关于首次回购公司股份的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the company's first share repurchase (buyback) activity. It details the number of shares repurchased, prices, total amount spent, and compliance with relevant regulations. It does not contain financial statements or performance data but focuses on the share repurchase transaction itself. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company buying back its own shares.
2023-10-27 Chinese
独立董事对第五届董事会第十次（临时）会议相关事项的独立意见
Transaction in Own Shares Classification · 100% confidence The document is an independent directors' opinion on a share repurchase plan by the company. It discusses the legality, compliance, and rationale of the share buyback, including its funding source and impact on shareholders and company control. There is no financial data or report content, but rather a formal opinion related to a share repurchase transaction. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2023-10-26 Chinese
关于回购公司股份方案的公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding a share repurchase plan. It includes specifics about the type of shares to be repurchased, the purpose (for equity incentives or employee stock ownership plans), price limits, total funds allocated, duration, and the impact on shareholding structure. It also discusses the legal basis, risk factors, management analysis, and authorizations related to the share buyback. The document is not a financial report, earnings release, or management discussion but a formal announcement of a share repurchase plan. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company announcements about buying back or selling its own shares. The document length is sufficient and contains substantive details about the repurchase plan, not just a brief notice or a report publication announcement.
2023-10-26 Chinese
第五届董事会第十次（临时）会议决议公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement of a board meeting resolution regarding a share repurchase plan by the company. It includes specifics on the purpose, conditions, price range, quantity, funding source, implementation period, and authorization for the share buyback. The document is not a financial report or earnings release but a formal announcement of a capital action (share repurchase). It is not a brief notice but a full announcement of the share repurchase plan approved by the board. Therefore, it fits the category of Transaction in Own Shares (POS). The document length is 3285 characters, which is sufficient for a detailed announcement but not a full financial report. Hence, the classification is POS with high confidence.
2023-10-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.